Evidence map›Paper›PMID 36188294›Full record

ArticleACS omega2022

Structure and Enzymatic Activity of an Intellectual Disability-Associated Ornithine Decarboxylase Variant, G84R.

X Edward Zhou, Chad R Schultz, Kelly Suino Powell, Amy Henrickson, Jared Lamp, Joseph S Brunzelle, Borries Demeler, Irving E Vega, André S Bachmann, Karsten Melcher

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

X Edward ZhouDepartment of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, United States.
Chad R SchultzDepartment of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan 49546, United States.
Kelly Suino PowellDepartment of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, United States.
Amy HenricksonDepartment of Chemistry and Biochemistry, The University of Lethbridge, Lethbridge, AB T1K3M4, Canada.ORCID https://orcid.org/0000-0003-3266-5202
Jared LampDepartment of Translational Neuroscience, Integrated Mass Spectrometry Unit, College of Human Medicine, Michigan State University, Grand Rapids, Michigan 49503, United States.ORCID https://orcid.org/0000-0002-7187-7657
Joseph S BrunzelleNorthwestern University Synchrotron Research Center, Life Sciences Collaborative Access Team, Northwestern University, Argonne, Illinois 60439, United States.
Borries DemelerDepartment of Chemistry and Biochemistry, The University of Lethbridge, Lethbridge, AB T1K3M4, Canada.ORCID https://orcid.org/0000-0002-2414-9518
Irving E VegaDepartment of Translational Neuroscience, Integrated Mass Spectrometry Unit, College of Human Medicine, Michigan State University, Grand Rapids, Michigan 49503, United States.
André S BachmannDepartment of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan 49546, United States.ORCID https://orcid.org/0000-0002-6510-8560
Karsten MelcherDepartment of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, United States.ORCID https://orcid.org/0000-0002-9125-4027
Michigan State University · USVan Andel Institute · USUniversity of Lethbridge · CANorthwestern University · US

Funding

Development of an UltraScan Meta-Scheduler for HPC Job SubmissionR01GM120600 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Emre H. Brookes, BORRIES DEMELER · 2016 to 2026
$3.6M
NIGMS NIH HHS R01 GM120600
6 · The paper itself

Abstract

Ornithine decarboxylase (ODC) is a rate-limiting enzyme for the synthesis of polyamines (PAs). PAs are required for proliferation, and increased ODC activity is associated with cancer and neural over-proliferation. ODC levels and activity are therefore tightly regulated, including through the ODC-specific inhibitor, antizyme AZ1. Recently, ODC G84R has been reported as a partial loss-of-function variant that is associated with intellectual disability and seizures. However, G84 is distant from both the catalytic center and the ODC homodimerization interface. To understand how G84R modulates ODC activity, we have determined the crystal structure of ODC G84R in both the presence and the absence of the cofactor pyridoxal 5-phosphate. The structures show that the replacement of G84 by arginine leads to hydrogen bond formation of R84 with F420, the last residue of the ODC C-terminal helix, a structural element that is involved in the AZ1-mediated proteasomal degradation of ODC. In contrast, the catalytic center is essentially indistinguishable from that of wildtype ODC. We therefore reanalyzed the catalytic activity of ODC G84R and found that it is rescued when the protein is purified in the presence of a reducing agent to mimic the reducing environment of the cytoplasm. This suggests that R84 may exert its neurological effects not through reducing ODC catalytic activity but through misregulation of its AZ1-mediated proteasomal degradation.

Identifiers

PMID36188294
PMCPMC9520691
OpenAlexW4296017122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.